Pfizer Inc. (PFE), Tuesday announced that Mikael Dolsten will step down from the role of Chief Scientific Officer, and President, Pfizer Research & Development.
The drug manufacturer also stated that Dolsten will continue to serve in his current position until a successor is appointed.
To identify a new chief scientific officer, Pfizer will initiate an external search which is expected to last through early next year.
Currently, Pfizer's stock is moving down 1.84 percent, to $ 27.42 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.